NEW YORK, April 6, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories,
Inc. (NYSE: FRX), an international manufacturer and marketer of pharmaceutical
products, will release its Fiscal 2009 Fourth Quarter financial results before
the U.S. stock market opens on Tuesday, April 21, 2009. Later that day, at
10:00 AM EDT, Forest will host a conference call where Dr. Lawrence Olanoff,
President and Chief Operating Officer and Frank Perier, Senior Vice
President-Finance and Chief Financial Officer, will discuss the financial
results and relevant company and industry topics. The conference call will be
webcast live beginning at 10:00 AM ET on the Company's website www.frx.com and
also on the website www.streetevents.com. Please log on to either website at
least fifteen minutes prior to the conference call as it may be necessary to
download software to access the call. A replay of the conference call will be
available until May 5, 2009 at both websites and also by dialing
1-800-642-1687 (US investors) or +1-706-645-9291 (international investors),
Conference Call ID 92011267.
(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO)
About Forest Laboratories
Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company
with a long track record of building partnerships and developing and marketing
products that make a positive difference in people's lives. In addition to its
well-established franchises in therapeutic areas of the central nervous and
cardiovascular systems, Forest's current pipeline includes product candidates
in all stages of development and across a wide range of therapeutic areas. The
company is headquartered in New York, NY. To learn more about Forest
Laboratories, visit www.frx.com.
Except for the historical information contained herein, this release
contains forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements involve a number
of risks and uncertainties, including the difficulty of predicting FDA
approvals, the acceptance and demand for new pharmaceutical products, the
impact of competitive products and pricing, the timely development and launch
of new products, and the risk factors listed from time to time in Forest
Laboratories' Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and
any subsequent SEC filings.
CONTACT: Frank J. Murdolo
Vice President - Investor Relations, Forest Laboratories, Inc.
1-212-224-6714
frank.murdolo@frx.com
SOURCE Forest Laboratories, Inc.
Web Site: http://www.frx.com
(FRX)